CVS Health Corp. bought health insurer Aetna Inc. for nearly $70 billion. Cigna Corp. paid about $54 billion for pharmacy-benefits manager Express Scripts Holding Co.
These deals and others have been powerful consolidating forces in the U.S. health industry, with high price tags accompanied by investment-grade bond issuances.
Now they prompt a new question: Is financial risk also getting concentrated?
